SIPA1L1 and Cirrhosis: To confirm that SIPA1L1 and hemopexin were potential biomarkers for the detection of liver fibrosis and cirrhosis respectively, both candidates were measured by ELISA in a large validation group of CCl4-treated rats with different degrees of liver fibrosis.